Cerexa expands portfolio of novel anti-infective therapies through in-licensing agreement with Meiji Seika Kaisha

News | 11. 01. 2006

Cerexa

Cerexa Inc. today announced it has expanded its portfolio of novel anti-infective therapies through an in-licensing agreement with Meiji Seika Kaisha Ltd.